Evidence map›Paper›PMID 39201280›Full record

ReviewInternational journal of molecular sciences2024

Development of Antimicrobial Surfaces Using Diamond-like Carbon or Diamond-like Carbon-Based Coatings.

Yasuhiro Fujii, Tatsuyuki Nakatani, Daiki Ousaka, Susumu Oozawa, Yasushi Sasai, Shingo Kasahara

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yasuhiro FujiiCenter for Innovative Clinical Medicine, Okayama University Hospital, Okayama University, Okayama 700-8558, Japan.
Tatsuyuki NakataniInstitute of Frontier Science and Technology, Okayama University of Science, Okayama 700-0005, Japan.ORCID 0000-0001-5027-362X
Daiki OusakaDepartment of Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.ORCID 0000-0002-8577-9062
Susumu OozawaDivision of Medical Safety Management, Safety Management Facility, Okayama University Hospital, Okayama University, Okayama 700-8558, Japan.
Yasushi SasaiDepartment of Pharmacy, Gifu University of Medical Science, Kani 509-0293, Japan.ORCID 0000-0002-2176-7855
Shingo KasaharaDepartment of Cardiovascular Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.

Funding

Research grant-in-aid of Chugoku Regional Innovation Research Center 2024 N/AResearch grant-in-aid of Miyata Cardiac Research Promotion Foundation 2300010314Special Power Source Prefecture Science and Technology Promotion Project Subsidy Project in Okayama prefecture 2024 N/Athe Promotion of Science Grants-in-Aid for Scientific Research 21K08823,22K08936, 23K08235, 23K08236, 24K11974, and 24K11952
6 · The paper itself

Abstract

The medical device market is a high-growth sector expected to sustain an annual growth rate of over 5%, even in developed countries. Daily, numerous patients have medical devices implanted or inserted within their bodies. While medical devices have significantly improved patient outcomes, as foreign objects, their wider use can lead to an increase in device-related infections, thereby imposing a burden on healthcare systems. Multiple materials with significant societal impact have evolved over time: the 19th century was the age of iron, the 20th century was dominated by silicon, and the 21st century is often referred to as the era of carbon. In particular, the development of nanocarbon materials and their potential applications in medicine are being explored, although the scope of these applications remains limited. Technological innovations in carbon materials are remarkable, and their application in medicine is expected to advance greatly. For example, diamond-like carbon (DLC) has garnered considerable attention for the development of antimicrobial surfaces. Both DLC itself and its derivatives have been reported to exhibit anti-microbial properties. This review discusses the current state of DLC-based antimicrobial surface development.

Indexed as

Anti-Infective AgentsCarbonCoated Materials, BiocompatibleDiamondHumansSurface PropertiesAnti-Infective AgentsCarbonCoated Materials, BiocompatibleDiamondantibacterial surfacebacterial adhesionbiofilmdiamond-like carbonhydrophilicitysurface smoothnessζ-potential

Identifiers

PMID39201280
PMCPMC11354288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.